Histone deacetylase 3 is required for maintenance of bone mass during aging
about
Histone deacetylase 7 (Hdac7) suppresses chondrocyte proliferation and β-catenin activity during endochondral ossificationHistone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1Biological regulation of bone quality.Genetic determinants of phosphate response in Drosophila.Aberrant bone density in aging mice lacking the adenosine transporter ENT1.Conditional deletion of Hdac3 in osteoprogenitor cells attenuates diet-induced systemic metabolic dysfunction.The effect of laser therapy on the expression of osteocalcin and osteopontin after tooth extraction in rats treated with zoledronate and dexamethasone.Histone Deacetylases in Bone Development and Skeletal Disorders.Hdac3 Deficiency Increases Marrow Adiposity and Induces Lipid Storage and Glucocorticoid Metabolism in Osteochondroprogenitor CellsDeletion of the intestinal plasma membrane calcium pump, isoform 1, Atp2b1, in mice is associated with decreased bone mineral density and impaired responsiveness to 1, 25-dihydroxyvitamin D3.Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient miceHistone deacetylase 3 suppression increases PH domain and leucine-rich repeat phosphatase (Phlpp)1 expression in chondrocytes to suppress Akt signaling and matrix secretionSclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calciumSilencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death.Sclerostin deficient mice rapidly heal bone defects by activating β-catenin and increasing intramembranous ossification.Bone cell senescence: mechanisms and perspectives.Towards selective inhibition of histone deacetylase isoforms: what has been achieved, where we are and what will be next.Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.Targeting cellular senescence prevents age-related bone loss in mice.Epigenetics and Bone Remodeling.Kynurenine, a Tryptophan Metabolite That Accumulates With Age, Induces Bone Loss.Deletion of protein kinase D1 in osteoprogenitor cells results in decreased osteogenesis in vitro and reduced bone mineral density in vivo.Histone deacetylases and their roles in mineralized tissue regenerationLoss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin sensitivity.Histone deacetylase 3 suppresses Erk phosphorylation and matrix metalloproteinase (Mmp)-13 activity in chondrocytes.Histone Deacetylase 3 Deletion in Mesenchymal Progenitor Cells Hinders Long Bone Development.
P2860
Q28251460-72F32DED-12B8-467A-A735-BB781F7E5B19Q33614697-E6A87393-040A-4532-AB35-0F7BD972CA7EQ33784471-ABD0C309-EA5E-461B-80B5-8560CF225BABQ34051287-18E51459-A940-4689-9E58-5E63E31CF189Q34631633-0223C2FA-D178-4F41-A4F1-4AA130F897EDQ35106323-E3D5F624-96C4-4D8A-AFAF-992ABE60EB10Q35648782-58151837-5A79-4E69-91BA-415D838C7596Q35697018-5F79421A-12DA-4608-ABA7-EC085F374C7CQ36146330-95210780-0037-44F6-A297-B198BBF6AD73Q36593452-04FD024A-3881-4BD6-926C-AB0B034D8321Q36635803-9FE553F2-51A1-450E-A407-F312B2FA4805Q36635990-5A36A9EF-755D-46C8-AF6B-55FF8100B3BAQ36742145-9F55A57C-1026-46E6-B291-8CA7493B5545Q36762750-16A6CD1C-57FC-4C1B-93CE-2377A29AAD70Q37167523-022DB6FB-93EC-4EBB-AF48-D531B1E59615Q37421796-863335A9-1D1F-4A62-9099-46BEC0F5D72FQ38185298-6B6754D6-3172-4651-B923-6E14B6D753C8Q38204386-C3ED7522-458D-4E67-9B77-FD1FAF659D18Q38402465-78F6D7A9-B0A2-4A55-895F-6A379FBE3888Q38616265-EC135C62-A521-49DA-8756-32D3D0216313Q38624611-EE22693D-98AB-4605-A6B6-0B2B28FEA16DQ38670358-48386C77-B52F-45A0-ADFC-3603DEBB2178Q40082136-876D74A8-64F4-4CF1-9B26-95FCBE0193F1Q41479037-6316E08E-1BFC-4618-8253-AE347FFD7D99Q42003109-12441C6A-EB3F-4482-9FF8-66389530E3CAQ47105192-9E740587-900F-49B0-B2EF-B8A7E8D60B16Q47984258-D9B19350-E4B9-4FA1-BD80-C35825C3706A
P2860
Histone deacetylase 3 is required for maintenance of bone mass during aging
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Histone deacetylase 3 is required for maintenance of bone mass during aging
@ast
Histone deacetylase 3 is required for maintenance of bone mass during aging
@en
type
label
Histone deacetylase 3 is required for maintenance of bone mass during aging
@ast
Histone deacetylase 3 is required for maintenance of bone mass during aging
@en
prefLabel
Histone deacetylase 3 is required for maintenance of bone mass during aging
@ast
Histone deacetylase 3 is required for maintenance of bone mass during aging
@en
P2093
P2860
P1433
P1476
Histone deacetylase 3 is required for maintenance of bone mass during aging
@en
P2093
Amel Dudakovic
Jennifer J Westendorf
Kai-Nan An
Mahrokh Dadsetan
Michael J Yaszemski
Qingshan Chen
Rajiv Kumar
Samuel W Carlson
Zachary C Ryan
P2860
P304
P356
10.1016/J.BONE.2012.10.015
P577
2012-10-18T00:00:00Z